News – Page 1049 – Endpoints News

Stock flies high on Clearside’s PhIII macular edema trial results as drug improves vision

8 years ago

Chinese medicine player Tasly considers Hong Kong IPO for its biotech arm: report

8 years ago

Watch out below: Dermira axes acne drug after a catastrophic PhIII failure

8 years ago

Santhera’s Raxone fails NIH’s MS study in latest setback, shares plunge

8 years ago

Gene editing expert Homology details the numbers in its back-ended $1B Novartis deal, files for $100M IPO

8 years ago

Is tech money bad for business? Silicon Valley cash makes some biopharma VCs bristle, others cheer

8 years ago

Celgene hands over $101M in cash to launch a research collaboration with protein player Vividion

8 years ago

Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold

8 years ago

EpimAb nabs Bin Peng from NIBR; Jeffrey Chodakewitz exits Vertex; Christiana Stamoulis is president at Unum

8 years ago

Activist investor Alex Denner in the spotlight again as the Medicines Company shrinks its board

8 years ago

Perlara collaborates with Harvard/Undiagnosed Diseases Network; Verona shares soar on positive CF data

8 years ago

Amid a boisterous fundraising week, BioMedPartners airs $107M biotech fund

8 years ago

Asian investor commits $15M to launch new protein degradation biotech startup Cullgen out of UNC

8 years ago

What's up at stealthy Calico Labs? AI star Daphne Koller makes an abrupt exit as top team shrinks

8 years ago

Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases

8 years ago

Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential

8 years ago

With Restasis in its crosshairs, Mylan adds a Botox biosim with Revance; Vertex starts second PhIII triple combo CF ...

8 years ago

Watch out Endo: Sorrento is after your $1B+ drug with FDA OK of ZTlido

8 years ago

Novartis wants to be a leader in a new generation of prescription digital med programs, pairs with Pear

8 years ago

It’s official: EMA to move into permanent Amsterdam premises in November ‘19 amid continued protests from Italy

8 years ago

Takeda-partnered Finch Therapeutics grabs $36M and looks to leapfrog the pack in microbiome R&D

8 years ago

PureTech's Gelesis brings in $30M to back its FDA pitch on a new weight loss therapy with troublesome data

8 years ago

Sucking up talent out of Novartis, a booming Rubius adds another $100 million mega-round to the kitty

8 years ago

Scopia snags two board seats at Acorda following stock purchase; BeiGene nabs second indication for Revlimid in China

8 years ago

First page Previous page 1046 1047 104810491050 1051 1052 Next page Last page